aTyr Pharma | LIFE




Peers Price Chg Day Year Date
Ardelyx 3.78 0.04 1.07% -39.03% Aug/25
Biogen 220.68 2.56 1.17% 61.41% Aug/25
Bristol-Myers Squibb 67.92 0.64 0.95% 43.87% Aug/25
Clal Biotechnology 23.50 -0.40 -1.67% -21.93% Aug/25
Compugen 797.20 38.80 5.12% 64.92% Aug/25
Cipla 1,410.60 -11.40 -0.80% -10.74% Aug/26
Curis 1.59 0.01 0.63% -95.24% Aug/25
CSL 172.44 -1.20 -0.69% -20.06% Aug/26
Lakefront Biotherapeutics 25.53 0.09 0.35% -9.47% Aug/26
Grifols 8.09 0.10 1.25% -17.78% Aug/25


aTyr Pharma traded at $0.57 this Tuesday August 25th, increasing $0.04 or 7.55 percent since the previous trading session. Looking back, over the last four weeks, aTyr Pharma gained 16.42 percent. Over the last 12 months, its price fell by 88.91 percent. Looking ahead, we forecast aTyr Pharma to be priced at 0.49 by the end of this quarter and at 0.46 in one year, according to Trading Economics global macro models projections and analysts expectations.

aTyr Pharma Inc is a United States-based biotechnology company. The Company engaged in the development of medicines based on biology. The Company’s research and development efforts are concentrated on a new discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases.